Lathosterol (Normalized) Test

Your body gets cholesterol from two places: it absorbs some from food through the gut, and it builds the rest from scratch, mostly in the liver. These two pathways exist in a seesaw relationship. When absorption goes up, production tends to go down, and vice versa. Knowing which side of that seesaw you sit on changes what you should do about high cholesterol, because statins target production while other drugs target absorption.

Normalized lathosterol answers that question directly. Lathosterol is a molecule your liver produces as an intermediate step while building cholesterol. The more cholesterol your body manufactures, the more lathosterol leaks into your bloodstream. By dividing your lathosterol level by your total cholesterol (the "normalized" part), the test creates a ratio that reflects your personal rate of cholesterol production, independent of how much total cholesterol happens to be circulating.

How the Synthesis/Absorption Balance Works

A systematic review covering obesity, diabetes, cardiovascular disease, and liver conditions confirmed that cholesterol-standardized lathosterol reliably reflects the body's internal cholesterol production across a wide range of metabolic conditions. People can be classified as "cholesterol synthesizers" (high normalized lathosterol, low absorption markers) or "cholesterol absorbers" (low normalized lathosterol, high absorption markers like campesterol and beta-sitosterol). This classification is more than academic: it helps predict which cholesterol-lowering strategy will work best for a given person.

The original validation study in 67 human subjects showed that the lathosterol-to-cholesterol ratio correlates strongly with directly measured whole-body cholesterol synthesis and drops by roughly 47% with statin therapy. That strong, predictable response is what makes it useful for tracking whether a statin is actually suppressing your cholesterol production.

Heart Disease Risk

The relationship between this marker and cardiovascular outcomes is not straightforward, and understanding the pattern matters more than chasing a single "good" or "bad" number.

In the CACHE CVD analysis of roughly 2,900 Japanese adults, a pattern of high cholesterol absorption combined with low cholesterol synthesis was associated with increased odds of cardiovascular disease, particularly coronary artery disease. The Framingham Offspring Study found a similar pattern in about 570 participants: lower synthesis markers and higher absorption markers independently predicted coronary heart disease, even after adjusting for standard risk factors.

The LURIC study followed roughly 1,260 patients referred for coronary angiography. Those with high absorption and low synthesis markers had higher all-cause and cardiovascular mortality. A separate study of 377 patients being evaluated for suspected coronary artery disease found that low serum lathosterol specifically predicted fatal cardiovascular events and excess all-cause mortality in people not taking lipid-lowering medications.

Why Low Lathosterol Can Signal Higher Risk

At first glance, this seems backwards. High lathosterol is linked to worse metabolic traits: higher body weight, larger waist, higher fasting blood sugar, higher insulin, higher triglycerides, and lower HDL cholesterol. So how can low lathosterol predict worse cardiovascular outcomes?

The answer is that normalized lathosterol is not a "lower is better" or "higher is better" marker. It is a metabolic-type indicator. A person with low synthesis and high absorption has a cholesterol problem driven by a different mechanism than someone with high synthesis. People with the high-absorption pattern may face artery disease risk through pathways that standard statin therapy does not fully address, which could explain why these individuals fare worse in outcome studies. In contrast, high synthesizers, despite their less favorable metabolic profile, tend to respond well to statins, which directly target their primary problem.

Metabolic Conditions

Obesity and insulin resistance tilt the balance toward higher synthesis. A study of 305 adults found that lean, insulin-sensitive individuals had higher cholesterol absorption, while those who were insulin-resistant or obese showed increased cholesterol synthesis. This shift is reflected in higher normalized lathosterol.

Metabolic dysfunction-associated steatotic liver disease (MASLD, previously called non-alcoholic fatty liver disease) follows the same pattern. A study of 167 adults found that MASLD is characterized by increased cholesterol production and an impaired synthesis-to-absorption balance. If your lathosterol is elevated alongside signs of fatty liver, it confirms that overproduction is part of the metabolic picture.

Kidney function also matters. In the CACHE CKD analysis of nearly 3,000 participants, lower kidney function was associated with lower cholesterol synthesis markers and higher absorption markers. If you have reduced kidney function, your lathosterol may read lower than it otherwise would, not because your liver is producing less cholesterol on its own, but because kidney disease shifts the entire balance toward the absorption side.

Sex and Age Differences

In a study of 100 healthy middle-aged adults, men had higher cholesterol synthesis than women, while women had higher cholesterol absorption. These sex-specific patterns were associated with differences in predicted cardiovascular risk using the SCORE2 model, with synthesis markers correlating more strongly with risk in women. This suggests that the same lathosterol value may carry different implications depending on your sex.

Lathosterol also changes with age. A study of 130 healthy individuals across different age groups found that lathosterol concentrations vary from newborns through adulthood, reinforcing the need to interpret your result in the context of your age and compare against age-appropriate data when possible.

When Results Can Be Misleading

Cholesterol synthesis follows a daily cycle, peaking during the nighttime hours. A systematic review confirmed that synthesis markers including lathosterol show daily variation under standardized conditions. Extended fasting beyond 18 hours can also suppress lathosterol and abolish its normal daily rhythm. For the most consistent results, have your blood drawn in the morning after a standard overnight fast of 10 to 14 hours, and avoid extremely prolonged fasts before testing.

Acute illness or infection can temporarily lower lathosterol. In a controlled study, a brief inflammatory response induced by a bacterial toxin significantly reduced cholesterol synthesis markers within 24 hours in healthy young men. If you have recently been sick, wait at least two to three weeks after recovery before testing to avoid a falsely low reading.

Statin medications dramatically lower lathosterol (by roughly 47%), which is their intended effect. If you are taking a statin, your lathosterol will be low by design, not because you are naturally a low synthesizer. This is important context when your lab report arrives. Thyroid treatment for Graves' disease (hyperthyroidism) can raise cholesterol synthesis as thyroid function normalizes, producing a lathosterol increase that reflects changing metabolism rather than a new problem.

Different labs measuring the same sample can produce different numbers for lathosterol and other non-cholesterol sterols. Always compare your results within the same laboratory and the same method to get a meaningful trend.

Tracking Your Trend

A single lathosterol reading is a snapshot, not a verdict. Lathosterol has high within-person biological variation, meaning your number can shift from one draw to the next even when nothing about your health has changed. A study of 25 healthy adults confirmed this high variability for lathosterol and related sterol markers. This means a single elevated or low result should always be confirmed with a repeat test before drawing conclusions about your cholesterol metabolism type.

Get a baseline reading, then retest in three to six months, especially if you are starting a statin, changing your diet, or losing weight. Once your pattern is established, annual testing is reasonable for ongoing monitoring. If you are making active changes to your cholesterol management, more frequent testing (every three to four months) helps you see whether the intervention is shifting your synthesis-to-absorption balance in the expected direction.

What to Do With Your Results

Your normalized lathosterol result is most useful when interpreted alongside your absorption markers (campesterol and beta-sitosterol) and your standard lipid panel. Together, they paint a picture of your cholesterol metabolism type.

• High normalized lathosterol (synthesizer type): Your body is producing a lot of cholesterol. Statins, which block the liver enzyme responsible for cholesterol production, are likely to be effective for you. A study of 306 high-risk patients found that baseline synthesis and absorption marker patterns could predict how well atorvastatin would lower LDL cholesterol.
• Low normalized lathosterol with high absorption markers (absorber type): Your cholesterol problem is driven more by gut absorption than liver production. Ezetimibe, which blocks cholesterol absorption in the intestine, may be a better fit, either alone or combined with a statin. A randomized trial of 246 patients found that adding ezetimibe to statin therapy produced greater coronary plaque regression in patients who already had prior statin use, a group that tends to include more absorbers.
• Mixed or unclear pattern: Retest in three months to confirm. Consider ordering the full Sterols Panel, which includes campesterol, beta-sitosterol, and desmosterol alongside lathosterol, plus a Cholesterol Balance Score that integrates these markers into a single synthesis-versus-absorption assessment.

If your lipid panel shows elevated LDL cholesterol and your normalized lathosterol helps identify your type, a lipid specialist can use that information to choose between a statin, ezetimibe, or a combination. If your results are persistently extreme in either direction, a lipid specialist can also screen for rarer genetic conditions that affect cholesterol metabolism.